Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00943930 · ClinicalTrials.gov registry record
Marijuana Drug Discrimination and Self-Administration
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 29
- Enrollment target
NCT00943930 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 29 participants.
The verdict
NCT00943930 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This study is designed to investigate the associations among marijuana's discriminative stimulus, reinforcing, subjective (e.g. craving) and physiological effects, and to assess the relative ability of oral THC to block these effects.
Interventions
- DRUG THC (delta-9 tetrahydrocannabinol), d-amphetamine, oral THC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00943930
The ClinicalTrials.gov registry entry for NCT00943930 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which THC (delta-9 tetrahydrocannabinol), d-amphetamine, oral THC is the first listed.
NCT00943930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00943930 about?
NCT00943930 is a clinical study titled "Marijuana Drug Discrimination and Self-Administration". This study is designed to investigate the associations among marijuana's discriminative stimulus, reinforcing, subjective (e.g. craving) and physiological effects, and to assess the relative ability of oral THC to block these effects.
What is the current status of trial NCT00943930?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2009-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00943930?
The interventions under investigation include: THC (delta-9 tetrahydrocannabinol), d-amphetamine, oral THC (DRUG).
Who is sponsoring clinical trial NCT00943930?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.